My understanding is that “viruses infect cells via receptor-mediated fusion, entering the host cell by binding to receptors on its surface.”In the COVID-19 case the key receptor is ACE2. There may be mutations but ACE2 remains the target of COVID-19.
RLF-100 shields the ACE2 receptors and protects host cell from injury.